Now showing items 1-6 of 6
HIV Subtype D Is Associated with Dementia, Compared with Subtype A, in Immunosuppressed Individuals at Risk of Cognitive Impairment in Kampala, Uganda
(Clinical Infectious Diseases, 2009)
Background. In the United States, clade B is the predominant human immunodeficiency virus (HIV) subtype, whereas in sub-Saharan Africa, clades A, C, and D are the predominant subtypes. HIV subtype may have an impact on ...
Subclinical atherosclerosis among HIV-infected adults attending HIV/AIDS care at two large Ambulatory HIV clinics in Uganda
(PLOS One, 2014)
Background: The increased immune activation and inflammation of chronic HIV-infection and the characteristic dyslipidemias associated with HIV infection and antiretroviral therapy (ART) contribute to an increased risk of ...
Cognitive dysfunction among HIV positive and HIV negative patients with psychosis in Uganda
(Public Library of Science, 2012)
Background: Cognitive impairment is an established phenomenon in HIV infected individuals and patients that have psychosis. However there is need to establish the severity of the impairment if patients are co morbid with ...
Antiretroviral therapy improves cognitive impairment in HIV individuals in Sub-Saharan Africa
(American Academy of Neurology (AAN), 2006)
Abstract—Background: Highly active antiretroviral therapy (HAART) can improve cognitive performance in some patients with HIV-associated cognitive impairment in the United States. The effect of HAART on HIV dementia ...
Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda
(BMC Psychiatry, 2010)
Background: Among patients with HIV infection, depression is the most frequently observed psychiatric disorder. The presence of depressive symptoms and cognitive dysfunction among HIV patients has not been well studied in ...
Benefits and risks of stavudine therapy for HIV-associated neurologic complications in Uganda
(American Academy of Neyurology, 2009)
Background: The frequency of HIV dementia in a recent study of HIV individuals at the Infectious Disease Institute in Kampala, Uganda, was 31%. Coformulated generic drugs, which include stavudine, are the most common ...